INTRODUCTION {#sec1-1}
============

It is well known that percutaneous coronary intervention (PCI) is superior to fibrinolysis for ST elevation myocardial infarction (STEMI), but fibrinolysis remains a good option for centers without PCI facility or geographical inaccessibility.

Several trials have consistently shown no differences in mortality between primary PCI and thrombolysis when performed within 2 hours of symptom onset,\[[@ref1]\] provided they can be transferred to PCI hospital for rescue or angiography in order to decide on final treatment of culprit lesion.

The objective of this study was to assess the delay of fibrinolysis in STEMI in order to identify factors associated with prolonged delay.

PATIENTS AND METHODS {#sec1-2}
====================

We conducted a prospective study between January 1, 2007 and December 30, 2009. Two hundred and fifty patients with STEMI were treated in the department of cardiology of Farhat Hached Hospital, which is one of the two teaching hospitals in Sousse, but without PCI capability.

All cases included patients who consulted directly the emergency department or patients who were transferred from other peripheral hospital. Maximum distance from a peripheral hospital to our emergency department was 20 km.

The following patients were excluded sequentially: patient who underwent primary PCI, patients who had contraindication to fibrinolysis, patients who had a delay from symptom onset to hospital arrival \> 12 h.

Time to fibrinolysis was defined as time from the first diagnostic electrocardiogram for STEMI to thrombolytic administration.

Inter-department decision was defined as the decision to give fibrinolysis when it was validated by a cardiologist and not by general practitioner in the emergency department.

Statistical analysis: Univariate analysis was constructed to estimate the associations between delay of fibrinolysis for all patients and hospital characteristics.

A *P* value of \< 0.05 was considered statistically significant for all the tests and test of statistical significance were two-tailed.

All analyses were performed using Statistical Package for the Social Science (SPSS) software version 17.

RESULTS {#sec1-3}
=======

Overall characteristics of the patient cohort are reported in [Table 1](#T1){ref-type="table"}.

###### 

Baseline characteristics of study cohort
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Median time to reperfusion was 46 min.

Seventy percent of patients were treated within 6 h of onset of symptom and 30% between 6 and 12 h from symptom onset to hospital presentation.

For transferred patients, median time to reperfusion was 110 min. Only 15% were treated within 6 hours of onset of symptoms. Time to transfer from other centers differ from geographic situation, median time was 42 min.

In univariate analysis, the factors most strongly associated with long delay to reperfusion treatment were transfer from regional hospital to our center, inter-department decision, age, and diabetes \[[Table 2](#T2){ref-type="table"}\].

###### 

Patient characteristics according to reperfusion time
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After multivariate analysis, the association between reperfusion time and baseline characteristics remained largely unchanged, factors associated with long reperfusion time were inter-department decision OR 6; 95% CI 3,48-10,34, diabetes OR 2,25; 95% CI 1,28-3,96; age \> 58,(± 4 years) OR 1,97; 95% CI 1,19-3,25; and transfer from regional hospital to our center OR 1,78; 95% 1,03-3.07.

DISCUSSION {#sec1-4}
==========

It is known that fibrinolytic therapy reduce mortality in STEMI and this reduction was greater when the treatment was administrated as soon as possible after the onset of symptoms.\[[@ref2][@ref3]\]

Compared to fibrinolytic therapy, PCI is the preferred initial reperfusion strategy for STEMI. In our region, despite the presence of three catheterization laboratories and a mobile intensive care unit system, patients still consulted directly the emergency department.

Some studies have shown clearly that mortality was similar for patients treated with thrombolysis and routine subsequent invasive strategy compared with primary PCI,\[[@ref1][@ref3]\] and because the door to balloon times are often greater than 2 hours in our region, we preferred to use a pharmaco-invasive strategy which consist of starting fibrinolysis and then, transfer the patient to PCI center.

We found that median time to reperfusion was 46 min. This time was lower than that found in 2001 (46 min vs 60 min)\[[@ref4]\] but we consider that it is still too long, indeed guidelines states that STEMI patients presenting to a hospital without PCI capability and who cannot be transferred to undergo PPCI within 90 min of first medical contact should be treated with fibrinolytic therapy within 30 min of hospital presentation unless fibrinolytic therapy is contraindicated.\[[@ref5]\]

The medical system goal is to facilitate rapid recognition and treatment of patients with STEMI so that door-to-needle (or medical contact-to-needle) for initiation of fibrinolytic therapy can be achieved within 30 min or door-to-balloon (or medical contact-to-balloon) for PCI can be achieved within 90 min. These goals should not be understood as \"ideal\" times, but rather the longest times that should be considered acceptable for a given system.\[[@ref6]\]

In the European Heart Survey Acute Coronary Syndrome (EHS ACS) registry in 2008, 17% of all eligible patients for reperfusion therapy were treated with fibrinolysis and 2/3 were performed in the cardiology unit.\[[@ref2]\] In this study 65.8% of fibrinolysis was performed in \< 30 min, but this registry doesn't represent the real world because the participants' centers were recruited on a purely voluntary basis and we cannot exclude the possibility that participating centers were much more motivated than those who do not participate.\[[@ref2][@ref7]\] Indeed, Glickman studying 3219 STEMI patients in 178 hospitals found that only 44.5% met the American College of Cardiology guideline of time to fibrinolysis \< 30 min.\[[@ref8]\]

In our study, reperfusion time was too late because of the delay of inter-department decision. Rajagopalan has found that visits to the general practitioner were an independent factor correlated to delay of reperfusion in patients with STEMI.\[[@ref9]\] General practitioners working in our emergency department prefer to ask a cardiologist\'s opinion before thrombolysis, and this may loose more time for the patient. In the last year, we have started an educational program to the physicians who are working in the emergency department to demystify the risk of fibrinolytic treatment and to facilitate fibrinolysis without the presence of the cardiologist and we hope that it will improve delay to reperfusion time in STEMI.

The second problem was transferring patients from peripheral hospitals. In our study, we found that patients who were transferred loose at least one hour for the transfer times. It is well known that bypassing closer hospitals capable of providing fibrinolytic therapy will increase time to treatment.\[[@ref10]\] Glickman has found in his study including 3219 STEMI patients who received fibrinolysis at non PCI hospitals had significantly longer treatment times (median 35 minutes) than those treated in PCI - capable hospitals (median 27 minutes).\[[@ref7]\]

Some other factors can contribute to lengthen delay of reperfusion like age, diabetes, and delay in presentation; indeed, Ting, found a correlation between delay in presentation and reperfusion therapy; patients with longer times between symptom onset and hospital presentation were significantly less like to receive any reperfusion therapy.\[[@ref11]\]

Study limitation {#sec2-1}
----------------

We think that the reperfusion time in our emergency department doesn't represent the real time in our region because we have excluded patients who have pre-hospital fibrinolysis by mobile intensive care unit system. As a consequence, this may reduce reperfusion time in our region.

CONCLUSION {#sec1-5}
==========

The median time to reperfusion in our center was too long. This constitutes a problem to effective new therapies of AMI. It is therefore essential to reduce this delay. To achieve this objective, real effort should be made, to think about health organization between multidisciplinary teams especially emergency medicine and cardiologist. The reduction of reperfusion time in STEMI may be enhanced through focused analysis of key steps within the care process to identify system problems and implement quality improvement initiatives.
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